Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: A population-based study

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 9, 2015, Pages 856-866

  Koloski, N A ^a   Jones, M ^b   Young, M ^a   Talley, N J ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT TOOL; CLUSTER ANALYSIS; CONSTIPATION; CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMALE; FUNCTIONAL CONSTIPATION; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; IRRITABLE COLON; LATENT PERIOD; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; ROME III CLASSIFICATION; SYMPTOMATOLOGY; AGED; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADULT; AGED; AUSTRALIA; CONSTIPATION; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; PAIN;

EID: 84926421343     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13149     Document Type: Article

References (39)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
2. Herz MJ, Kahan E, Zalevski S, Aframian R, Kuznitz D, Reichman S. Constipation: a different entity for patients and doctors. Fam Pract 1996; 13: 156-9.
3. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004; 99: 750-9.
4. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking of the functional gastrointestinal disorders. A population-based study. Am J Gastroenterol 2000; 97: 2290-9.
5. Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001; 96: 3130-7.
6. Drossman DA, Li Z, Andruzzi E, et al. The U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
7. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94: 3530-40.
8. Rome Foundation. Guidelines-Rome III diagnostic criteria for functional gastrointestinal disorders. J Gastrointest Liver Dis 2006; 15: 307-12.
9. Shekhar C, Monaghan PJ, Morris J, et al. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 2013; 145: 749-57.
10. Zhao YF, Ma XQ, Wang R, et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC). Aliment Pharmacol Ther 2011; 34: 1020-9.
11. Talley NJ. Definition, epidemiology and impact of chronic constipation (Review). Rev Gastroenterological Dis 2004; 4: S3-16.
12. Chang JY, Locke GR 3rd, Schleck CD, et al. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil 2007; 19: 905-11.
13. Leung FW. Etiologic factors of chronic constipation: review of scientific evidence. Dig Dis Sci 2007; 52: 313-6.
14. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 2003; 98: 1107-11.
15. Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011; 106: 915-22.
16. Locke GR III, Pemberton JH, Phillips SF. AGA technical review on constipation. American Gastroenterological Association. Gastroenterology 2000; 119: 1766-78.
17. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012; 61: 1284-90.
18. Mearin R, Rey E. Subjects With Irritable Bowel Syndrome-Constipation are more constipated than those with chronic constipation: Spectrum From a Population Based Study. Gastroenterology 2012; 142: S-818-9.
19. Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III Criteria to Distinguish Functional Constipation From Constipation-Subtype Irritable Bowel Syndrome. Am J Gastroenterol 2010; 105: 2228-34.
20. rd ed. McLean, VA: Degnon Associates, 2006; 835-53.
21. National Health Survey: Users' Guide - Electronic Publication, 2007-08.
22. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
23. Ware JE, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Health Summary Scales. Boston: The Health Institute, New England Medical Center, 1999.
24. Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York: John Wiley, 1978.
25. Sood R, Law GR, Ford AC. Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'?Nat Rev Gastroenterol Hepatol 2014; 11: 683-91.
26. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007; 25: 599-608.
27. Sun SX, Dibonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci 2011; 56: 2688-95.
28. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000; 95: 67-71.
29. Gilia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol 1997; 32: 1083-9.
30. Chang L. Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20(Suppl. 7): 31-9.
31. Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007; 26: 227-36.
32. Wald A, Hinds JP, Caruana BJ. Psychological and physiological characteristics of patients with severe idiopathic constipation. Gastroenterology 1989; 97: 932-7.
33. Wald A, Burgio K, Holeva K, Locher J. Psychological evaluation of patients with severe idiopathic constipation. Which instrument to use? Am J Gastroenterol 1992; 87: 977-80.
34. Preston DM, Pfeffer JM, Lennard-Jones JE. Psychiatric assessment of patients with severe constipation. Gut 1984; 25: A582.
35. Cheng C, Chan AOO, Hui WM, Lam SK. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: A population-based study. Aliment Pharmacol Ther 2003; 18: 319-26.
36. Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005; 23: 461-76.
37. Dibonaventura MD, Prior M, Prieto P, Fortea J. Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom. Clin Exp Gastroenterol 2012; 5: 203-12.
38. Heaton KW, O' Donnell LJD, Braddon FEM, et al. Symptoms of irritable bowel syndrome in a British urban community: Consulters and non-consulters. Gastroenterology 1992; 102: 1962-7.
39. Cook JV, Dickinson HO, Eccles MP. Response rates in postal surveys of healthcare professionals between 1996 and 2005: An observational study. BMC Health Serv Res 2009; 9: 160.